COVID-19 Project Team: Difference between revisions
Jump to navigation
Jump to search
TayyabaAli (talk | contribs) |
No edit summary |
||
| Line 10: | Line 10: | ||
; | ; | ||
* The name of the leaders are '''bold''': | |||
'''Cardiovascular Disorders of COVID-19 Team Members''' | '''Cardiovascular Disorders of COVID-19 Team Members''' | ||
*Alieh Bahjat | *Alieh Bahjat | ||
*[[User:Mandana Chitsazan|Mandana Chitsazan, M.D.]] | *'''[[User:Mandana Chitsazan|Mandana Chitsazan, M.D.]]''' | ||
*'''[[User:Mitra Chitsazan|Mitra Chitsazan]]''' | |||
*Mandana Safakhah | *Mandana Safakhah | ||
*Mounika Vadiyala | *Mounika Vadiyala | ||
*Sara Haddadi | *Sara Haddadi | ||
| Line 24: | Line 24: | ||
'''Dermatologic Disorders of COVID-19 Team Members''' | '''Dermatologic Disorders of COVID-19 Team Members''' | ||
*'''Aditya Ganti''' | |||
*[[user:Nuha|Nuha AL-Howthi, MD]] | *[[user:Nuha|Nuha AL-Howthi, MD]] | ||
*[[Ogechukwu Hannah Nnabude, MD]] | *[[Ogechukwu Hannah Nnabude, MD]] | ||
'''Frequently Asked Inpatient Questions Team Members''' | '''Frequently Asked Inpatient Questions Team Members''' | ||
* [[User:Gurman4sandhu|Gurmandeep Singh Sandhu, M.B.B.S.]] | * '''[[User:Gurman4sandhu|Gurmandeep Singh Sandhu, M.B.B.S.]]''' | ||
* [[User:Aisha Adigun|Aisha Adigun, M.D.]] | * [[User:Aisha Adigun|Aisha Adigun, M.D.]] | ||
* [[User:Harmeetkharoud91|Harmeet Kharoud, M.D,. MPH]] | * [[User:Harmeetkharoud91|Harmeet Kharoud, M.D,. MPH]] | ||
| Line 37: | Line 38: | ||
'''Frequently Asked Outpatient Questions Team Members''' | '''Frequently Asked Outpatient Questions Team Members''' | ||
* [[User:Roukoz Abou Karam|Roukoz Abou Karam, M.D.]] | * '''[[User:Roukoz Abou Karam|Roukoz Abou Karam, M.D.]]''' | ||
* [[User:Aisha Adigun|Aisha Adigun, M.D.]] | * [[User:Aisha Adigun|Aisha Adigun, M.D.]] | ||
* [[User:Bosky Soni|Bosky Soni, M.D., MPH]] | * [[User:Bosky Soni|Bosky Soni, M.D., MPH]] | ||
| Line 45: | Line 46: | ||
'''Hematologic disorders of COVID-19 Team Members''' | '''Hematologic disorders of COVID-19 Team Members''' | ||
*'''Ramyar Ghandriz''' | |||
* [[User:Ifrah Fatima|Ifrah Fatima, M.B.B.S]] | * [[User:Ifrah Fatima|Ifrah Fatima, M.B.B.S]] | ||
*Shakiba Hassanzade | *Shakiba Hassanzade | ||
| Line 50: | Line 52: | ||
'''Nephrologic Disorders of COVID-19 Team Members''' | '''Nephrologic Disorders of COVID-19 Team Members''' | ||
*'''[[User:Sogand Goudarzi|Sogand Goudarzi, M.D.]]''' | |||
*[[User:Gurman4sandhu|Gurmandeep Singh Sandhu, M.B.B.S.]] | *[[User:Gurman4sandhu|Gurmandeep Singh Sandhu, M.B.B.S.]] | ||
*[[User:NNikravangolsefid|Nasrin Nikravangolsefid, M.D, MPH]] | *[[User:NNikravangolsefid|Nasrin Nikravangolsefid, M.D, MPH]] | ||
| Line 56: | Line 58: | ||
'''Neurologic Disorders and COVID-19 Team Members''' | '''Neurologic Disorders and COVID-19 Team Members''' | ||
*Muhammad Adnan Haider | *Muhammad Adnan Haider | ||
*[[User:Agnesrinky|Rinky Agnes Botleroo, M.B.B.S.]] | *[[User:Agnesrinky|Rinky Agnes Botleroo, M.B.B.S.]] | ||
'''Ongoing Clinical Trials of COVID-19 Team Members''' | '''Ongoing Clinical Trials of COVID-19 Team Members''' | ||
* [[User:Hudakarman|Huda A. Karman M.D., M.P.H., M.S.]] | * '''[[User:Hudakarman|Huda A. Karman M.D., M.P.H., M.S.]]''' | ||
<br /> | <br /> | ||
| Line 68: | Line 68: | ||
* [[User:Harmeetkharoud91|Harmeet Kharoud, M.D,. MPH]] | * [[User:Harmeetkharoud91|Harmeet Kharoud, M.D,. MPH]] | ||
'''Pulmonary Disorders and COVID-19 Team Members''' | '''Pulmonary Disorders and COVID-19 Team Members''' | ||
*'''Sara Mohsin''' | |||
* Ayesha Farheen Javid | * Ayesha Farheen Javid | ||
* Usman Ali akbar | * Usman Ali akbar | ||
| Line 81: | Line 81: | ||
*Oluwabusola Adogba | *Oluwabusola Adogba | ||
*[[User:Rija Gul|Rija Gul, M.D.]] | *[[User:Rija Gul|Rija Gul, M.D.]] | ||
*Zaida Obeidat | *Zaida Obeidat | ||
*[[User:Vidhipatel|Vidhi Patel, M.B.B.S.]] | *[[User:Vidhipatel|Vidhi Patel, M.B.B.S.]] | ||
*Wajeeha Aiman | *Wajeeha Aiman | ||
<br /> | <br /> | ||
Revision as of 13:56, 12 June 2020
| COVID-19 Project |
|---|
| Introduction |
| Team |
| Meetings' Summary |
| Topics |
| Ongoing Clinical Trials |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]
Meet The Team
Associate Editor(s)-in-Chief:
- The name of the leaders are bold:
Cardiovascular Disorders of COVID-19 Team Members
- Alieh Bahjat
- Mandana Chitsazan, M.D.
- Mitra Chitsazan
- Mandana Safakhah
- Mounika Vadiyala
- Sara Haddadi
- Sara Zand
- Syed Rizvi
- Tayyaba Ali, M.D.
Dermatologic Disorders of COVID-19 Team Members
- Aditya Ganti
- Nuha AL-Howthi, MD
- Ogechukwu Hannah Nnabude, MD
Frequently Asked Inpatient Questions Team Members
- Gurmandeep Singh Sandhu, M.B.B.S.
- Aisha Adigun, M.D.
- Harmeet Kharoud, M.D,. MPH
- Rinky Agnes Botleroo, M.B.B.S.
- Nuha AL-Howthi, MD
- Ifrah Fatima, M.B.B.S
- Ogechukwu Hannah Nnabude, MD
Frequently Asked Outpatient Questions Team Members
Gastrointestinal disorders and of COVID-19
Hematologic disorders of COVID-19 Team Members
- Ramyar Ghandriz
- Ifrah Fatima, M.B.B.S
- Shakiba Hassanzade
- Fausat Adogba
Nephrologic Disorders of COVID-19 Team Members
- Sogand Goudarzi, M.D.
- Gurmandeep Singh Sandhu, M.B.B.S.
- Nasrin Nikravangolsefid, M.D, MPH
- Mydah Sajid
Neurologic Disorders and COVID-19 Team Members
- Muhammad Adnan Haider
- Rinky Agnes Botleroo, M.B.B.S.
Ongoing Clinical Trials of COVID-19 Team Members
Pediatrics and COVID-19
Pulmonary Disorders and COVID-19 Team Members
- Sara Mohsin
- Ayesha Farheen Javid
- Usman Ali akbar
- Rina Ghorpade
- Rana Aljebzi (not trained yet)
Radiologic Manifestations of COVID-19 Team Members
Other Team Members
- Oluwabusola Adogba
- Rija Gul, M.D.
- Zaida Obeidat
- Vidhi Patel, M.B.B.S.
- Wajeeha Aiman